Improving blood pressure control among adults with CKD and diabetes: Provider-focused quality improvement using electronic health records

Advances in Chronic Kidney Disease

Volumn 18, Issue 6, 2011, Pages 406-411

  Thomas, Bernadette ^a,b  

^a USA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

CKD; Clinical practice guidelines; Electronic health records; Primary care; Scorecards

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; FEEDBACK SYSTEM; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; NURSE; PATIENT EDUCATION; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; COMORBIDITY; CONNECTICUT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORDS; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; MALE; PATIENT COMPLIANCE; QUALITY IMPROVEMENT; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 81255211373     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2011.10.005     Document Type: Review

References (47)

1. Atkins R.C. The epidemiology of chronic kidney disease. Kidney Int Suppl 2005, 94:S14-S18.
2. Narenpitak S., Narenpitak A. Prevalence of chronic kidney disease in type 2 diabetes in primary health care unit of Udon Thani province, Thailand. J Med Assoc Thai 2008, 91:1505-1513.
3. Sasso F.C., De Nicola L., Carbonara O., et al. Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy. Diabetes Care 2006, 29:498-503.
4. Tam T.K., Cheng L.P., Lau D.M., et al. The prevalence of microalbuminuria among patients with type II diabetes mellitus in a primary care setting: cross-sectional study. Hong Kong Med J 2004, 10:307-311.
5. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2009, United States Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
6. Wen C.P., Cheng T.Y., Tsai M.K., et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008, 371:2173-2182.
7. Castro A.F., Coresh J. CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 2009, 53(suppl 3):S46-S55.
8. Collins A.J., Chen S.C., Gilbertson D.T., Foley R.N. CKD surveillance using administrative data: impact on the health care system. Am J Kidney Dis 2009, 53(suppl 3):S27-S36.
9. Whaley-Connell A.T., Sowers J.R., McFarlane S.I., et al. Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008, 51(suppl 2):S21-S29.
10. Prevalence of chronic kidney disease and associated risk factors-United States, 1999-2004. Morb Mortal Wkly Rep 2007, 56:161-165. Centers for Disease Control and Prevention.
11. Rahman M., Pressel S., Davis B.R., et al. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006, 144:172-180.
12. Dreyer G., Hull S., Aitken Z., Chesser A., Yaqoob M.M. The effect of ethnicity on the prevalence of diabetes and associated chronic kidney disease. QJM 2009, 102:261-269.
13. Gao S., Manns B.J., Culleton B.F., et al. Prevalence of chronic kidney disease and survival among aboriginal people. J Am Soc Nephrol 2007, 18:2953-2959.
14. Kiberd B. The chronic kidney disease epidemic: stepping back and looking forward. J Am Soc Nephrol 2006, 17:2967-2973.
15. Norris K.C., Agodoa L.Y. Unraveling the racial disparities associated with kidney disease. Kidney Int 2005, 68:914-924.
16. Peralta C.A., Hicks L.S., Chertow G.M., et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension 2005, 45:1119-1124.
17. Bello A.K., Peters J., Rigby J., Rahman A.A., El Nahas M. Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom. Clin J Am Soc Nephrol 2008, 3:1316-1323.
18. Merkin S.S., Coresh J., Roux A.V., Taylor H.A., Powe N.R. Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2005, 46:203-213.
19. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
20. de Galan B.E., Perkovic V., Ninomiya T., et al. Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol 2009, 20:883-892.
21. Shiba N., Matsuki M., Takahashi J., Tada T., Watanabe J., Shimokawa H. Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. Circ J 2008, 72:173-178.
22. Jayapaul M.K., Messersmith R., Bennett-Jones D.N., Mead P.A., Large D.M. The joint diabetic-renal clinic in clinical practice: 10 years of data from a District General Hospital. QJM 2006, 99:153-160.
23. Arora P., Mustafa R.A., Karam J., et al. Care of elderly patients with chronic kidney disease. Int Urol Nephrol 2006, 38:363-370.
24. Charles R.F., Powe N.R., Jaar B.G., Troll M.U., Parekh R.S., Boulware L.E. Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians. Am J Kidney Dis 2009, 54:227.
25. Fox C.H., Brooks A., Zayas L.E., McClellan W., Murray B. Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med 2006, 19:54-61.
26. Israni R.K., Shea J.A., Joffe M.M., Feldman H.I. Physician characteristics and knowledge of CKD management. Am J Kidney Dis 2009, 54:238-247.
27. Lea J.P., McClellan W.M., Melcher C., Gladstone E., Hostetter T. CKD risk factors reported by primary care physicians: do guidelines make a difference?. Am J Kidney Dis 2006, 47:72-77.
28. Lenz O., Fornoni A. Chronic kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey. BMC Med 2006, 4:30.
29. New J.P., Middleton R.J., Klebe B., et al. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med 2007, 24:364-369.
30. Wasse H., McClellan W.M. Increasing physician knowledge about the diagnosis and management of CKD: how can we help primary care providers?. Am J Kidney Dis 2009, 54:187-190.
31. Bailie G.R., Eisele G., Liu L., et al. Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects. Nephrol Dial Transplant 2005, 20:1110-1115.
32. Boulware L.E., Troll M.U., Jaar B.G., Myers D.I., Powe N.R. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis 2006, 48:192-204.
33. Minutolo R., De Nicola L., Zamboli P., et al. Management of hypertension in patients with CKD: differences between primary and tertiary care settings. Am J Kidney Dis 2005, 46:18.
34. Thomas M.C., Atkins R. Assessment and management of hypertension in patients with type 2 diabetes. Intern Med J 2009, 39:143-149.
35. De Nicola L., Minutolo R., Chiodini P., et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 2006, 69:538-545.
36. Minutolo R., De Nicola L., Zamboli P., et al. Management of hypertension in patients with CKD: differences between primary and tertiary care settings. Am J Kidney Dis 2005, 46:18-25.
37. Thomas M.C. The assessment and management of albuminuria in primary care. Diabetes Res Clin Pract 2008, 80:83-88.
38. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, 2002. Available at: Accessed June 28, 2009. http://www.kidney.org/professionals/KDOQI/guidelines_ckd/p4_class_g1.htm.
39. Standards of medical care in diabetes. Diabetes Care 2011, 34(suppl 1):S11-S61. American Diabetes Association.
40. Flack J.M., Sica D.A., Bakris G., et al. Management of high blood pressure in Blacks: an update of the international society on hypertension in blacks consensus statement. Hypertension 2010, 56:780-800.
41. Faria C., Wenzel M., Lee K.W., Coderre K., Nichols J., Belletti D.A. A narrative review of clinical inertia: focus on hypertension. J Am Soc Hypertens 2009, 3:267.
42. Phillips L.S., Branch W.T., Cook C.B., et al. Clinical inertia. Ann Intern Med 2001, 135:825-834.
43. Phillips L.S., Twombly J.G. It's time to overcome clinical inertia. Ann Intern Med 2008, 148:783-785.
44. Salisbury C., Fahey T. Overcoming clinical inertia in the management of hypertension. CMAJ 2006, 174:1285-1286.
45. Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet, 2010.
46. Nutting P.A., Miller W.L., Crabtree B.F., Jaen C.R., Stewart E.E., Stange K.C. Initial lessons from the first national demonstration project on practice transformation to a patient-centered medical home. Ann Fam Med 2009, 7:254-260.
47. U.S. Department of Health and Human Services HRaSA. Health Center Data. 2008; Available at: Accessed April 10, 2011. http://bphc.hrsa.gov/healthcenterdatastatistics/nationaldata/2008/2008datasnapshot.html.